Ever since the first reports earlier this year of using the CRISPR/Cas system to modify individual gene function in human cells it has been inevitable that we would see whole-genome modification screens.  The first two such reports are out today in Science and look very interesting.  Genome-wide combination (e.g. synthetic lethal) screens cannot be far behind.  Does this signal the end of genome-wide RNAi screening?

Comment